Clinical Knowledge Graphs for Genomics Global Market Report 2026

The clinical knowledge graphs for genomics market size has grown exponentially in recent years. It will grow from $1.46 billion in 2025 to $1.76 billion in 2026 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to increasing genomic research initiatives, adoption of early clinical knowledge graph platforms, rising demand for precision medicine, growth of bioinformatics tools, expanding clinical research data sets.

The clinical knowledge graphs for genomics market size is expected to see exponential growth in the next few years. It will grow to $3.74 billion in 2030 at a compound annual growth rate (CAGR) of 20.7%. The growth in the forecast period can be attributed to growing integration of AI-driven analytics, increasing use of cloud-based deployment models, rising demand for personalized medicine solutions, expansion of genomic data annotation services, increasing focus on drug discovery applications. Major trends in the forecast period include increasing adoption of cloud-based knowledge graph platforms, rising demand for genomic data integration software, growing focus on variant interpretation and annotation tools, expansion of visualization and network analytics solutions, rising implementation of consulting and custom knowledge modeling services.

The increasing adoption of precision medicine is expected to propel the growth of the clinical knowledge graphs for the genomics market. Precision medicine is a medical approach that tailors disease prevention and treatment based on an individual’s genetic makeup, environment, and lifestyle. Its growing adoption is driven by advances in genomic technologies, declining sequencing costs, and increased focus on targeted and personalized therapies. Clinical knowledge graphs support precision medicine by structuring and integrating these complex relationships, enabling clinicians and researchers to identify personalized treatment options, predict drug responses, and uncover novel therapeutic targets more efficiently. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the US food and drug administration approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, increasing adoption of precision medicine is driving the growth of the clinical knowledge graphs for the genomics market.

Major companies operating in the clinical knowledge graphs for the genomics market are focusing on developing innovative solutions such as, genomic variant interpretation to enable precise disease diagnosis, personalized treatment recommendations, and accelerated drug discovery. Genomic variant interpretation refers to the process of analyzing differences in an individual’s DNA sequence to determine their potential impact on health, disease risk, or treatment response, helping clinicians and researchers make informed decisions in precision medicine. For instance, in December 2024, Genomenon Inc., a US-based genomic intelligence company, launched the genomenon genomic graph (G³) knowledgebase, an innovative AI-driven platform that consolidates the entirety of clinically relevant empirical genomics evidence into a single searchable graph and powers advanced predictive models for clinical diagnostics and drug development applications. The G³ knowledgebase combines patient and biological data from nearly all published scientific and medical studies, uses proprietary curated datasets to train its underlying large language models for enhanced accuracy, provides natural language search and structured generative AI insights, and enables the discovery of novel clinical and genomic relationships previously buried in literature.

In May 2025, John Snow Labs, a US-based healthcare AI and data analytics company, completed the acquisition of WiseCube for an undisclosed amount. Through this acquisition, John Snow Labs seeks to enhance and protect its medical AI models by incorporating WiseCube’s knowledge graph technology, thereby improving data relationships, reasoning capabilities, and clinical decision support. WiseCube is a US-based technology company specializing in knowledge graph solutions for healthcare and life sciences applications.

Major companies operating in the clinical knowledge graphs for genomics market are UnitedHealth Group, Microsoft Corporation, IBM Corporation, Bayer AG, Oracle Corporation, AstraZeneca plc, BC Platforms Ltd., RELX plc, Illumina Inc., Tempus AI Inc., Neo4j Inc., SOPHiA GENETICS SA, Seven Bridges Genomics Inc., DNAnexus Inc., Lifebit Biotech Ltd., Fabric Genomics Inc., PierianDx Inc., Elsevier, Ontotext Corporation, Biorelate Ltd., Ingentium Inc., Genomenon Inc., and Medvolt A.

North America was the largest region in the clinical knowledge graphs for genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical knowledge graphs for genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical knowledge graphs for genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical knowledge graphs for the genomics market includes revenues earned by entities by providing services such as data integration, precision medicine support, and predictive analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical knowledge graphs for genomics are structured, graph-based frameworks that combine genomic data with clinical, biological, and biomedical knowledge to aid interpretation and decision-making. They link entities such as genes, variants, diseases, phenotypes, drugs, and clinical guidelines through defined relationships, enabling efficient querying, inference, and discovery of clinically relevant genomic insights for diagnosis, prognosis, and precision medicine.

The essential components of clinical knowledge graphs for genomics include software and services. Software platforms integrate and analyze genomic, clinical, and biomedical data using knowledge graph frameworks to support advanced insights and decision-making. Deployed through on-premises and cloud-based models, they are applied in drug discovery, disease diagnosis, personalized medicine, clinical research, and other applications, serving hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other end-users.

Tariffs on imported software tools, cloud infrastructure components, and specialized analytics platforms are affecting the clinical knowledge graph market by raising costs for software providers and healthcare organizations. Segments such as cloud-based platforms, variant interpretation software, and visualization tools are most affected, particularly in regions like North America, Europe, and Asia-Pacific that rely on imported technology solutions. While tariffs increase operational expenses, they also encourage local software development, regional cloud infrastructure adoption, and investment in cost-efficient, high-performance platforms, offering long-term growth opportunities.

The clinical knowledge graphs for genomics market research report is one of a series of new reports that provides clinical knowledge graphs for genomics market statistics, including clinical knowledge graphs for genomics industry global market size, regional shares, competitors with a clinical knowledge graphs for genomics market share, detailed clinical knowledge graphs for genomics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical knowledge graphs for genomics industry. This clinical knowledge graphs for genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.